G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
Restrictions on the cultivation and ingestion of fava beans were first reported as early as the fifth century BC. Not until the late 19th century were clinical descriptions of fava-induced disease reported and soon after characterised as “favism” in the early 20th century. It is now well known that...
Main Authors: | Germana Bancone, Cindy S. Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.638885/full |
Similar Items
-
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
by: Sasithon Pukrittayakamee, et al.
Published: (2024-02-01) -
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
by: Cindy S. Chu, et al.
Published: (2018-03-01) -
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
by: Sara Avalos, et al.
Published: (2018-11-01) -
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar
by: Jinyoung Lee, et al.
Published: (2018-03-01) -
Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas
by: Rosalind E. Howes, et al.
Published: (2017-04-01)